In addition, it was able to inhibit hTERT expression and colorectal cancer cell growth by targeting cpsf4 [123], to reverse ABCB1-mediated drug resistance in colorectal cancer [124], and to regulate mTOR and ERK signaling pathways in gastric cancer cells [125]. This evidence concerns the gene MTOR and colorectal cancer.